MXCT
MaxCyte, Inc. · Healthcare
EVP, Global Sales Thomas M. Ross sold $136K of MaxCyte, Inc.
Sold$136,465
$4.09Price
33,333Shares
−57%Stake
What MXCT did after the filing
- The stock from Mon, Jun 24 close, $4.19
- +6.2%
- S&P 500, same days
- −3.8%
Measured over 30 trading days, to the Aug 6 close.
Traded Thu, Jun 20. Filed Mon, Jun 24, 12:17 PM ET, during the session. Returns use the Jun 24 close and the Aug 6 close. Not investment advice.